Multiple Sclerosis, 1 June 2003, vol. 9, no. 3, pp. 293-298(6)
Weinstock-Guttman B.; Jacobs L.D.; Brownscheidle C.M.; Baier M.; Rea D.F.; Apatoff B.R.; Blitz K.M.; Coyle P.K.; Frontera A.T.; Goodman A.D.; Gottesman M.H.; Herbert J.; Holub R.; Lava N.S.; Lenihan M.; Lusins J.; Mihai C.; Miller A.E.; Perel A.B.; Snyder D.H.; Bakshi R.; Granger C.V.; Greenberg S.J.; Jubelt B.; Krupp L.; Munschauer F.E.; Rubin D.; Schwid S.; Smiroldo J.; The New York State Multiple Sclerosis Consortium
 William C. Baird Multiple Sclerosis Research Center, The Jacobs Neurological Institute, Buffalo, NY 14203, USA  Neurological Associates of Albany, Albany, NY 12208, USA  Department of Neurology, Albany Medical College, Albany, NY 12208, USA  Glens Falls Neurology, Glens Falls, NY 12801, USA  Catskill Neuroscience and Radiology Associates, Oneonta, NY 13820, USA  Department of Neurology, SUNY Upstate Medical University, Syracuse, NY 13210, USA  Division of Neurology, Maimonides Medical Center, Brooklyn, NY 11219, USA  Staten Island University Hospital, Staten Island, NY 10306, USA  New York Hospital Medical Center of Queens, Flushing, NY 11355, USA  Uniform Data System for Medical Rehabilitation, State University of New York at Buffalo  Center for Research Methodology and Biometrics, AMC Cancer Research Center, Lakewood, CO 80214, USA  Department of Neurology and Neuroscience, Cornell Medical Center, New York, NY 10021, USA  Multiple Sclerosis Care Center, North Shore University Hospital at East Meadow, East Meadow, NY 11554, USA  Department of Neurology, State University of New York at Stony Brook University Hospital, Stony Brook, NY 11794, USA  Kingston Neurological Associates, Kingston, NY 12401, USA  Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA  Division of Neurology, Winthrop-University Hospital, Mineola, NY 11501, USA  The Hospital for Joint Diseases/Orthopedic Institute, MS Care Center, New York, NY 10003, USA
The objective of this study was to determine the clinical characteristics of multiple sclerosis (MS) in African American (AA) patients in the New York State Multiple Sclerosis Consortium (NYSMSC) patient registry.
The NYSMSC is a group of 18 MS centers throughout New York State organized to prospectively assess clinical characteristics of MS patients.
AAs comprise 6% (329) of the total NYSMSC registrants (5602).
Demographics, disease course, therapy, and socioeconomic status were compared in AA registrants versus nonAfrican Americans (NAA).
There was an increased female preponderance and a significantly younger age at diagnosis in the AA group.
AA patients were more likely to have greater disability with increased disease duration.
No differences were seen in types of MS and use of disease modifying therapies.
Our findings suggest a racial influence in MS.
Further genetic studies that consider race differences are warranted to elucidate mechanisms of disease susceptibility.